Endovascular Repair of Type B Aortic Dissection
Thoracic endovascular aortic repair (TEVAR) represents a therapeutic concept for type B aortic dissection. Long-term outcomes and morphology after TEVAR for uncomplicated dissection are unknown.
Methods and Results—
A total of 140 patients with stable type B aortic dissection previously randomized to optimal medical treatment and TEVAR (n=72) versus optimal medical treatment alone (n=68) were analyzed retrospectively for aorta-specific, all-cause outcomes, and disease progression using landmark statistical analysis of years 2 to 5 after index procedure. Cox regression was used to compare outcomes between groups; all analyses are based on intention to treat. The risk of all-cause mortality (11.1% versus 19.3%;
P
=0.13), aorta-specific mortality (6.9% versus 19.3%;
P
=0.04), and progression (27.0% versus 46.1%;
P
=0.04) after 5 years was lower with TEVAR than with optimal medical treatment alone. Landmark analysis suggested a benefit of TEVAR for all end points between 2 and 5 years; for example, for all-cause mortality (0% versus 16.9%;
P
=0.0003), aorta-specific mortality (0% versus 16.9%;
P
=0.0005), and for progression (4.1% versus 28.1%;
P
=0.004); Landmarking at 1 year and 1 month revealed consistent findings. Both improved survival and less progression of disease at 5 years after elective TEVAR were associated with stent graft induced false lumen thrombosis in 90.6% of cases (
P
<0.0001).
Conclusions—
In this study of survivors of type B aortic dissection, TEVAR in addition to optimal medical treatment is associated with improved 5-year aorta-specific survival and delayed disease progression. In stable type B dissection with suitable anatomy, preemptive TEVAR should be considered to improve late outcome.
Clinical Trial Registration—
URL:
http://www.clinicaltrials.gov
. Unique identifier: NCT01415804.
No keywords indexed for this article. Browse by subject →
Michael D. Dake, Noriyuki Kato, R. SCOTT MITCHELL et al.
Thomas T. Tsai, Rossella Fattori, Santi Trimarchi et al.
Jacob Buth, Peter L. Harris, Roel Hobo et al.
Gregory A. Magee, Firas F. Mussa · 2026
Ali B. Khoynezhad, Baran Z. Kay · 2025
Aakash Shah, Justin Robinson · 2025
Xuyang Zhang, Shuaitong Zhang · 2025
Lucia Mazzolai, Gisela Teixidó-Turà · 2024
Wael Ahmad, Jan Brunkwall · 2023
R. Scott McClure, Thomas F. Lindsay · 2023
Joseph V. Lombardi · 2022
Lasse M. Obel, Jes S. Lindholt · 2022
Ryan Gouveia e Melo, Mariana Mourão · 2022
Fengshi Li, Xiaoyu Wu · 2021
Grace J. Wang, Benjamin M. Jackson · 2021
Petr Vařejka · 2021
Joseph V. Lombardi, G. Chad Hughes · 2020
Martin Czerny, Matthias Siepe · 2020
Randall R. DeMartino, Indrani Sen · 2018
G. Torsello, M. Czerny · 2018
Feng Liu, Yang Yang Ge · 2018
Christoph A. Nienaber, Rachel E. Clough · 2016
- Published
- Aug 01, 2013
- Vol/Issue
- 6(4)
- Pages
- 407-416
You May Also Like
Michael Werk, Thomas Albrecht · 2012
314 citations
Mahmood K. Razavi, Michael R. Jaff · 2015
244 citations
Mitchell J. Silver, C. Michael Gibson · 2023
153 citations
Ofer Havakuk, Sorel Goland · 2017
152 citations
Jeremiah R. Brown, John F. Robb · 2010
136 citations